Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.

Pharmacogenomics - 1 Jan 2015

Chan Sze Ling, Jin Shengnan, Loh Marie, Brunham Liam R

Abstract excerpt

A major goal of the field of pharmacogenomics is to identify the genomic causes of serious adverse drug reactions (ADRs). Increasingly, genome-wide association studies (GWAS) have been used to achieve this goal. In this article, we review recent progress in the identification of genetic variants associated with ADRs using GWAS and discuss emerging themes from these studies. We also compare aspects of GWAS for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Induced Adverse Reactions
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ethnicity

Share to Genetic Variation

Share to Genome-Wide Association Study

Share to Genomics

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Source

Identifiers

PMID: 25978008
DOI: 10.2217/pgs.15.54

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.PMID 25978008Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.Semantic proximity Read ↗

The emerging era of pharmacogenomics: current successes, future potential, and challenges.Semantic proximity Read ↗

Pharmacogenetics of Adverse Drug Reactions.Semantic proximity Read ↗

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Semantic proximity Read ↗

EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions.Semantic proximity Read ↗

Insights from genome-wide association studies of drug response.Semantic proximity Read ↗

Pharmacogenomics of adverse drug reactions: implementing personalized medicine.Semantic proximity Read ↗

Pharmacogenetics and adverse drug reactions.Semantic proximity Read ↗

Pharmacogenomics of adverse drug reactionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.